In Vivo Weight-Loss Efficacy of GLP-1R, GIPR, and GCGR Agents in DIO and Humanized Rodent Models
Explore in vivo approaches for evaluating next-generation obesity therapeutics targeting GLP-1R, GIPR, and GCGR. This webinar presents pharmacology data from DIO mice, rat models, and humanized models spanning single, dual, and triple GLP‑1R, GIPR, and GCGR targets, providing practical insights into model selection, weight-loss efficacy benchmarking, and translational assessment of metabolic drug candidates.